A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate

Br J Haematol. 2011 Jun;153(6):796-9. doi: 10.1111/j.1365-2141.2010.08490.x. Epub 2011 Apr 8.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cancer Vaccines / therapeutic use*
  • Dendritic Cells / transplantation*
  • Diphosphonates / immunology*
  • Female
  • Humans
  • Imidazoles / immunology*
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Treatment Outcome
  • WT1 Proteins / immunology*
  • Zoledronic Acid

Substances

  • Cancer Vaccines
  • Diphosphonates
  • Imidazoles
  • WT1 Proteins
  • Zoledronic Acid